ArticlePLOS global public health2026
Isolation of non-albicans Candida and associated factors among symptomatic women presenting with abnormal vaginal discharge at Mubende Regional Referral Hospital, Central Uganda: A cross-sectional study.
Article in PLOS global public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vulvovaginal infections contribute substantially to women's reproductive morbidity, yet little is known about the determinants of non-albicans Candida (NAC) in sub-Saharan Africa. Understanding population-level drivers is critical for prevention and control. We conducted a hospital-based analytic cross-sectional study among 314 symptomatic women aged 18-49 years presenting with abnormal vaginal discharge at the gynecologic clinic of Mubende Regional Referral Hospital, Central Uganda, between 1st May 2025 and 1st August 2025. High vaginal swabs were cultured and species identified using CHROM agar. Sociodemographic, behavioral, and clinical data were collected through structured interviews. Logistic regression identified determinants of NAC infection. The prevalence of NAC infection was 23.6% (74/314; 95% CI: 19.0-28.8). The most frequently isolated species were C. glabrata (41.9%) and C. tropicalis (29.7%). Key determinants included: having ≥2 sexual partners (aOR 9.41, 95% CI: 4.59-19.31), ≥ 3 vaginal infections in the past year (aOR 6.43, 95% CI: 3.21-12.89), HIV-positive status (aOR 5.37, 95% CI: 2.51-11.49), contraceptive use (aOR 2.70, 95% CI: 1.39-5.24), vaginal douching (aOR 2.25, 95% CI: 1.15-4.41), and recent antibiotic use (aOR 2.09, 95% CI: 1.06-4.11). NAC infections are highly prevalent among women with abnormal vaginal discharge in Uganda, driven by modifiable behavioral and clinical factors. Public health interventions should prioritize sexual health education, discourage vaginal douching, promote rational antibiotic use, and integrate screening and counselling for high-risk women, especially those with HIV. Interpretation should be cautious because alternative etiologies of vaginal discharge were not excluded and confirmatory species identification was not performed.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.